These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 8805554

  • 1. Solution structure and peptide binding of the SH3 domain from human Fyn.
    Morton CJ, Pugh DJ, Brown EL, Kahmann JD, Renzoni DA, Campbell ID.
    Structure; 1996 Jun 15; 4(6):705-14. PubMed ID: 8805554
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M, Rohner D, Bichsel S.
    Biochem Biophys Res Commun; 1996 Mar 27; 220(3):729-34. PubMed ID: 8607833
    [Abstract] [Full Text] [Related]

  • 8. The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains.
    Fernandez-Ballester G, Blanes-Mira C, Serrano L.
    J Mol Biol; 2004 Jan 09; 335(2):619-29. PubMed ID: 14672668
    [Abstract] [Full Text] [Related]

  • 9. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions.
    Simon JA, Schreiber SL.
    Chem Biol; 1995 Jan 09; 2(1):53-60. PubMed ID: 9383403
    [Abstract] [Full Text] [Related]

  • 10. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT, Serrano L, Wilmanns M.
    J Mol Biol; 1998 Aug 21; 281(3):513-21. PubMed ID: 9698566
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of Src, Fyn, and Lyn SH3-binding proteins: implications for a function of SH3 domains.
    Weng Z, Thomas SM, Rickles RJ, Taylor JA, Brauer AW, Seidel-Dugan C, Michael WM, Dreyfuss G, Brugge JS.
    Mol Cell Biol; 1994 Jul 21; 14(7):4509-21. PubMed ID: 7516469
    [Abstract] [Full Text] [Related]

  • 18. Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit.
    Pleiman CM, Hertz WM, Cambier JC.
    Science; 1994 Mar 18; 263(5153):1609-12. PubMed ID: 8128248
    [Abstract] [Full Text] [Related]

  • 19. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain.
    Lee CH, Saksela K, Mirza UA, Chait BT, Kuriyan J.
    Cell; 1996 Jun 14; 85(6):931-42. PubMed ID: 8681387
    [Abstract] [Full Text] [Related]

  • 20. Phage display selection of ligand residues important for Src homology 3 domain binding specificity.
    Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, Zoller MJ.
    Proc Natl Acad Sci U S A; 1995 Nov 21; 92(24):10909-13. PubMed ID: 7479908
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.